Purpose/Objective: To establish the optimal planning risk volume (PRV) to the lenses for nasal cavity and paranasal sinus cancer patients during image guided intensity modulated radiation therapy (IG-IMRT). Materials and Methods: Geometrical uncertainties of the lenses were evaluated for retrospective group (RG) of patients for whom PRV for lenses was not applied. Differences between planned and delivered maximum doses to the lenses were established for every fraction dose and for cumulative dose. Maximum doses were evaluated as a dose received by 0.02 cm 3 of the lenses. Finally, relations between dose differences and geometrical uncertainties were analysed to establish an optimal PRV for the lenses. The PRV was calculated according to the formula: et al. Radiother Oncol 2002) . Obtained results were evaluated in the prospective group (PG) of patients for whom calculated PRV was applied. Results: Retrospective study (RG) based on the 330 observations from 10 nasal cavity and paranasal sinus cancer patients. The average shifts of the lenses have not got any dominant directionality, and were lower than 1 mm for each direction. Nevertheless, intra-patient analysis shows large variation of the lenses position during IG-IMRT. The systematic and random errors equaled respectively: 0.6 mm and 2.3 mm in R-L direction; 0.8 mm and 1.6 mm in C-C direction; and 0.4 mm and 1.5 mm in A-P direction. The differences between planned and delivered doses have normal distribution (p=0.542, Shapiro-Wilk's test). High mobility of the lenses leads to the fact that only for 11.1% observations, the differences between planned and delivered doses are lower than 3%. The delivered doses were: higher than planned by 10% for 40.7% of observations; higher than 30% for 16.7 % of observations; and higher than 50% for 5.6% of observations. The calculated margins were respectively: 1.9 mm in R-L direction; 1.8 mm in C-C direction, and 1.3 mm in A-P direction. As a result, clinical PRV for lenses was established on 2 mm. To evaluate applied margin, an analysis of dose distributions for 10 prospectively treated patients (PG) was done. The dose distribution in planning target volume for the RG (without PRV) and for the PG (2 mm PRV for lenses) was comparable (p=0.122, Mann-Whitney test). The differences between planned and delivered doses in lenses were significantly smaller for PG (p=0.013, Kolmogorov-Smirnov test). For PG the delivered doses were: higher than planned by 10% for 17.4% of observations; higher than 30% for 3.3 % of observations; and higher than 50% for 0.8% of observations. Conclusions: Our study showed that for radiation therapy of nasal cavity and paranasal sinus cancer, the planning risk volume for the lenses could be defined as 2 mm. This margin does not affect on the dose distribution in planning target volume and effectively reduce the differences between planned doses and delivered doses in lenses.
